Type 2 diabetes diagnoses are rising twice as fast in women under 40 as in women over 40, new data shows. Type 2 diabetes is a...
A genomic test may help some women with breast cancer avoid chemotherapy, with near-identical outcomes in an international trial. The findings suggest patients with a low...
The FDA has delayed approval of camizestrant while it reviews new analyses submitted by AstraZeneca after advisers voted against the breast cancer drug. The US regulator...
The NHS has been urged to update its website after PCOS was renamed PMOS, or polyendocrine metabolic ovarian syndrome. Last week, the condition, thought to affect...
Only one per cent of women can name all five gynaecological cancers, new research suggests, as 21 women in the UK die every day of the...
Menstrual fluid collected from tampons could one day provide a simple, non-invasive way to measure a biomarker of nerve damage and potentially track disease activity in...
Artera has won FDA clearance for ArteraAI Breast, its breast cancer platform for patients with early-stage HR-positive, HER2-negative invasive breast cancer. ArteraAI Breast is the first...
